| Wissenschaftl. Titel | A Multicenter, Randomized, Double-Blind, Placebo and Active Comparator Controlled Phase 3 Study to Evaluate the Efficacy and Safety of ESK-001 in Patients with Moderate to Severe Plaque Psoriasis (ONWARD1) |
| Erkrankung |
Haut:
Schuppenflechte (Psoriasis)
|
| weitere Prüfzentren | |
| Kurzprotokoll | Kurzprotokoll |
erstellt 19.02.2025 Admin07
geändert 19.02.2025 Admin07